INNOVEX CO-INVEST FUND, L.P. 4
4 · Innovex International, Inc. · Filed Feb 27, 2026
Research Summary
AI-generated summary of this filing
Innovex (INVX) 10% Owner Innovex Co-Invest Fund, L.P. Sells Shares
What Happened
- Innovex Co-Invest Fund, L.P. (reported as a 10% owner) sold a total of 6,612,500 shares of Innovex International, Inc. on February 27, 2026. The transactions were reported as sales at $24.59 per share, generating aggregate proceeds of approximately $162.61 million. Footnotes state these shares were sold in an underwritten secondary offering (public offering price $25.75), with the fund receiving $24.59125 per share after underwriting discounts.
Key Details
- Transaction date: 2026-02-27. Report filed 2026-02-27 (no late filing indicated in the provided excerpt).
- Reported sale price: $24.59 per share (footnote: public offering price $25.75; net to seller $24.59125).
- Shares sold (line items): 4,902,244; 1,144,635; 271,279; 234,009; 116; 60,217 — total 6,612,500 shares.
- Total proceeds (approx.): $162,609,972 (~$162.6M).
- Shares owned after the transactions: not specified in the provided excerpt.
- Notable footnotes: F3 indicates the sales were part of an underwritten secondary offering; F7–F9 explain the general partner/control structure of related funds; F10 notes a managing partner’s disclaimer of beneficial ownership beyond pecuniary interest. This Form 4 is the second of two filings split due to the SEC EDGAR limit on reporting persons; the first was filed by Amberjack Capital Partners, L.P.
Context
- This was an institutional sale by a 10% owner in an underwritten secondary offering — typically a liquidity event for investors rather than a routine open-market insider sale by an executive. The filing and footnotes describe fund and general-partner relationships (Amberjack-affiliated funds) but do not indicate executive-level trading intent. Retail investors should view this as institutional selling tied to a secondary offering, not necessarily a company-specific red flag on its own.
Insider Transaction Report
Form 4
INNOVEX CO-INVEST FUND, L.P.
Director10% Owner
Transactions
- Sale
Common Stock
[F1][F7][F8][F9][F10]2026-02-27$24.59/sh−4,902,244$120,552,553→ 16,871,374 total(indirect: By Amberjack Capital Fund II, L.P.) - Sale
Common Stock
[F2][F7][F8][F9][F10]2026-02-27$24.59/sh−1,144,635$28,148,063→ 3,939,330 total(indirect: By Innovex Co-Invest Fund II, L.P.) - Sale
Common Stock
[F3][F7][F8][F9][F10]2026-02-27$24.59/sh−271,279$6,671,103→ 933,624 total(indirect: By Innovex Co-Invest Fund, L.P.) - Sale
Common Stock
[F4][F7][F8][F9][F10]2026-02-27$24.59/sh−234,009$5,754,586→ 805,355 total(indirect: By Intervale Capital Fund II, L.P.) - Sale
Common Stock
[F5][F7][F8][F9][F10]2026-02-27$24.59/sh−116$2,853→ 399 total(indirect: By Intervale Capital Fund II-A, L.P.) - Sale
Common Stock
[F6][F7][F8][F9][F10]2026-02-27$24.59/sh−60,217$1,480,814→ 207,240 total(indirect: By Intervale Capital Fund III, L.P.)
Footnotes (10)
- [F1]Consists of shares of common stock, par value $0.01 per share, of the Issuer held directly by Amberjack Capital Fund II, L.P. ("Common Stock") that were sold in an underwritten secondary offering (the "Offering") at a price to the public of $25.75 per share. Amberjack Capital Fund II, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.
- [F10](Continued from footnote 9) Mr. Turowsky disclaims beneficial ownership of such securities in excess of his pecuniary interests in the securities.
- [F2]Consists of shares of Common Stock held directly by Innovex Co-Invest Fund II, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Innovex Co-Invest Fund II, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.
- [F3]Consists of shares of Common Stock held directly by Innovex Co-Invest Fund, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Innovex Co-Invest Fund, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.
- [F4]Consists of shares of Common Stock held directly by Intervale Capital Fund II, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Intervale Capital Fund II, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.
- [F5]Consists of shares of Common Stock held directly by Intervale Capital Fund II-A, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Intervale Capital Fund II-A, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.
- [F6]Consists of shares of Common Stock held directly by Intervale Capital Fund III, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Intervale Capital Fund III, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.
- [F7]The general partner of (i) Amberjack Capital Fund II, L.P. is Amberjack Capital GP II, L.P., and the general partner of such general partner is Amberjack Capital Associates II, LLC, (ii) Innovex Co-Invest Fund II, L.P. is Innovex Co-Invest Fund II GP, L.P., and the general partner of such general partner is Innovex Co-Invest Associates, LLC, (iii) Innovex Co-Invest Fund, L.P. is Innovex Co-Invest Fund GP, L.P., and the general partner of such general partner is Innovex Co-Invest Associates, LLC, (iv) Intervale Capital Fund II, L.P. is Intervale Capital GP II, L.P., and the general partner of such general partner is Intervale Capital Associates II, LLC, (v) Intervale Capital Fund II-A, L.P. is Intervale Capital GP II, L.P., and the general partner of such general partner is Intervale Capital Associates II, LLC, and (vi) Intervale Capital Fund III, L.P. is Intervale Capital GP III, L.P., and the general partner of such general partner is Intervale Capital Associates III, LLC.
- [F8](Continued from footnote 7) Funds affiliated with Amberjack Capital Partners, L.P. ("Amberjack Capital Partners") are referred to as the "Amberjack Funds".
- [F9]By virtue of their relationships, the foregoing general partners control all voting and dispositive power over the reported shares held by such Amberjack Fund and therefore may be deemed to be the beneficial owner of such shares. The sole member of Amberjack Capital Associates II, LLC, Innovex Co-Invest Associates, LLC, Intervale Capital Associates II, LLC and Intervale Capital Associates III, LLC is Amberjack Capital Partners, and the general partner of Amberjack Capital Partners is Amberjack Management, LLC ("Amberjack Management"). By virtue of their relationships, Amberjack Capital Partners and Amberjack Management control all voting and dispositive power over the reported shares held by all the Amberjack Funds and therefore may be deemed to be the beneficial owner of such shares. Jason Turowsky is managing partner of Amberjack Management.